XLON
YTT
Market cap3.17bUSD
Apr 20, Last price
14.40GBP
Name
Zhejiang Yongtai Technology Co Ltd
Chart & Performance
P/E
—
P/S
0.26
EPS
—
Div Yield, %
—
Shrs. gr., 5y
0.97%
Rev. gr., 5y
6.00%
Revenues
4.59b
+11.18%
Net income
-478m
L-22.82%
CFO
-111m
L-66.31%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Zhejiang Yongtai Technology Co., Ltd. is a diversified enterprise actively involved in the research, development, manufacturing, distribution, and servicing of a broad spectrum of chemical products. These key areas encompass pharmaceuticals, agrochemicals, electronic chemicals, and materials essential for new energy lithium batteries. Their extensive product portfolio includes active pharmaceutical ingredients (APIs), a range of pharmaceutical intermediates (basic, advanced), pesticides, liquid crystal materials, and components for lithium-ion batteries. Furthermore, the company provides specialized contract manufacturing services. Established on October 11, 1999, by founders Ying Mei Wang and Ren Bao He, its headquarters are located in Taizhou, China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||